These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 22095929

  • 1. Quality of health in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
    Molgaard-Hansen L, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros-Svennilson J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology.
    Pediatr Blood Cancer; 2011 Dec 15; 57(7):1222-9. PubMed ID: 22095929
    [Abstract] [Full Text] [Related]

  • 2. Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
    Molgaard-Hansen L, Skou AS, Juul A, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology.
    Pediatr Blood Cancer; 2013 Dec 15; 60(12):1988-95. PubMed ID: 24038890
    [Abstract] [Full Text] [Related]

  • 3. Renal, gastrointestinal, and hepatic late effects in survivors of childhood acute myeloid leukemia treated with chemotherapy only--a NOPHO-AML study.
    Skou AS, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros-Svennilson J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology.
    Pediatr Blood Cancer; 2014 Sep 15; 61(9):1638-43. PubMed ID: 24760750
    [Abstract] [Full Text] [Related]

  • 4. Hearing Status in Survivors of Childhood Acute Myeloid Leukemia Treated With Chemotherapy Only: A NOPHO-AML Study.
    Skou AS, Olsen SØ, Nielsen LH, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (NOPHO).
    J Pediatr Hematol Oncol; 2019 Jan 15; 41(1):e12-e17. PubMed ID: 30550508
    [Abstract] [Full Text] [Related]

  • 5. Treatment-related deaths in second complete remission in childhood acute myeloid leukaemia.
    Molgaard-Hansen L, Möttönen M, Glosli H, Jónmundsson GK, Abrahamsson J, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO).
    Br J Haematol; 2011 Mar 15; 152(5):623-30. PubMed ID: 21241281
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
    Starý J, Kobylka P, Sedlácek P, Komrska V, Vávra V, Syrůcková Z, Smísek P, Hrubá A, Korínková P, Matĕjková E, Cukrová V, Dolezalová L, Loudová M, Sejkorová J, Kvĕch J.
    Cas Lek Cesk; 1998 Jun 15; 137(12):363-7. PubMed ID: 9721472
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Late effects in long-term survivors after treatment for childhood acute leukemia.
    Haddy TB, Mosher RB, Reaman GH.
    Clin Pediatr (Phila); 2009 Jul 15; 48(6):601-8. PubMed ID: 19264722
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Disability and health-related quality of life in long-term survivors of cancer in childhood in Brazil.
    Shimoda S, Horsman J, Furlong W, Barr R, de Camargo B.
    J Pediatr Hematol Oncol; 2008 Aug 15; 30(8):563-70. PubMed ID: 18799931
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
    Creutzig U, Büchner T, Sauerland MC, Zimmermann M, Reinhardt D, Döhner H, Schlenk RF.
    Cancer; 2008 Feb 01; 112(3):562-71. PubMed ID: 18076087
    [Abstract] [Full Text] [Related]

  • 14. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A, Billström R, Björ O, Ahlgren T, Hedenus M, Höglund M, Lindmark A, Markevärn B, Nilsson B, Sallerfors B, Brune M.
    Eur J Haematol; 2009 Aug 01; 83(2):99-107. PubMed ID: 19385987
    [Abstract] [Full Text] [Related]

  • 15. Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003.
    Molgaard-Hansen L, Möttönen M, Glosli H, Jónmundsson GK, Abrahamsson J, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO).
    Br J Haematol; 2010 Dec 01; 151(5):447-59. PubMed ID: 20955398
    [Abstract] [Full Text] [Related]

  • 16. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
    Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Lehrnbecher T.
    J Clin Oncol; 2004 Nov 01; 22(21):4384-93. PubMed ID: 15514380
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term health outcomes in survivors of childhood AML treated with allogeneic HSCT: a NOPHO-AML Study.
    Wilhelmsson M, Glosli H, Ifversen M, Abrahamsson J, Winiarski J, Jahnukainen K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (NOPHO).
    Bone Marrow Transplant; 2019 May 01; 54(5):726-736. PubMed ID: 30242226
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High health-related quality of life among long-term survivors of childhood acute lymphoblastic leukemia.
    Harila MJ, Salo J, Lanning M, Vilkkumaa I, Harila-Saari AH.
    Pediatr Blood Cancer; 2010 Aug 01; 55(2):331-6. PubMed ID: 20582965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.